Opportunities - Clinical Research in Singapore

20-40% cheaper as compared to USA and UK, therefore more opportunities coming up.

Singapore offers following benefits that have made Singapore an attractive location for clinical trials.

• Lower cost per patient,
• Vast patient population, combined with the
• Availability of motivated, experienced English-speaking investigators,
• The broad adoption of International Conference on Harmonization (ICH) and Good Clinical Practices (GCP)
• Clinical trial and pharmaceutical regulation comparable to USA and UK and time-to-time approval
• Corporate income tax (18%) is one of the lowest in the region
• Strong Intellectual property rights.
• Medical environment similar to US and EU
• Strong support from the government